A Prognostic Model for Drug-induced Liver Injury in China — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Prognostic Model for Drug-induced Liver Injury in China — Stella

Recruiting

Back to Drug-induced Liver Injury trials

Trial locations(13 sites)

China

Beijing 302 Hospital, Beijing, Beijing Municipality

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing You 'an Hospital, Capital Medical University, Beijing

Beijing Ditan Hospital, Beijing

Peking University Third Hospital, Beijing

Key details

Sponsor

Beijing Friendship Hospital

Enrollment target

~3,000 participants

Started

May 2022

Primary completion

December 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov